L-Dihydroorotic acid

CAS: 5988-19-2

Ref. TM-T4880

Produktinformation

• Name: L-Dihydroorotic acid
• Synonyme: LDihydroorotic acid, (4S)-2,6-Dioxo-1,3-diazinane-4-carboxylic acid, (4S)-Hexahydro-2,6-dioxo-4-pyrimidinecarboxylic acid, (S)-2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 4-Pyrimidinecarboxylic acid, hexahydro-2,6-dioxo-, (4S)-, 4-Pyrimidinecarboxylic acid, hexahydro-2,6-dioxo-, (S)-, <span class="text-smallcaps">L</span>-5,6-Dihydroorotic acid, <span class="text-smallcaps">L</span>-Dihydroorotate, <span class="text-smallcaps">L</span>-Dihydroorotic acid, Hydroorotic acid, <span class="text-smallcaps">L</span>-
• CAS: 5988-19-2

Beschreibung

L-Dihydroorotic acid, also known as (S)-4,5-dihydroorotate or dihydro-L-orotate, belongs to the class of organic compounds known as alpha amino acids and derivatives. Within the cell, L-dihydroorotic acid is primarily located in the cytoplasm and mitochondria. L-Dihydroorotic acid exists in all eukaryotes, ranging from yeast to humans. L-Dihydroorotic acid participates in a number of enzymatic reactions. In particular, L-Dihydroorotic acid can be biosynthesized from ureidosuccinic acid; which is catalyzed by the enzyme cad protein. In addition, L-Dihydroorotic acid and quinone can be converted into orotic acid; which is mediated by the enzyme dihydroorotate dehydrogenase (quinone), mitochondrial. In humans, L-dihydroorotic acid is involved in the pyrimidine metabolism pathway. L-Dihydroorotic acid is also involved in several metabolic disorders, some of which include UMP synthase deficiency (orotic aciduria), the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, Beta ureidopropionase deficiency, and dihydropyrimidinase deficiency.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 158.11
• Formel: C₅H₆N₂O₄
• Reinheit: 98%
• Farbe/Form: White To Off-White Crystalline Powder